Becker's Healthcare September 4, 2024
The cost of initial cancer screenings in the U.S. hit $43.2 billion in 2021. But, according to the Lown Institute, that number could be an underestimate.
In a Sept. 3 article, the institute cites an editorial in the Annals of Internal Medicine by H. Gilbert Wench, MD, pointing out that the estimate doesn’t account for overuse of screening or the downstream costs of screening harms. The institute asserts that Americans are “frequently screened for cancer inappropriately” when they are too young, too old or too frequently.
According to one study by Lown, nearly half of older adults were overscreened for colorectal, cervical or breast cancer. Another study found that a quarter of cancer centers don’t follow evidence-based federal guidelines...
Today's Sponsors
Today's Sponsor